Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025:
Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR–Agonisten... More >>
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:
Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe... More >>
Bitget Launchpool intègre GAIA à raison de plus de 4,7 millions de jetons-récompenses à la clé
VICTORIA, Seychelles, 30 juill. 2025 (GLOBE NEWSWIRE) — More >>
Ambiq Announces Pricing of Upsized Initial Public Offering
AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra–low–power semiconductor solutions for edge AI, today announced the pricing of its upsized initial... More >>
Mauritania trusts EllaLink for its new international submarine cable connection
DUBLIN and NOUAKCHOTT, Mauritania, July 29, 2025 (GLOBE NEWSWIRE) — EllaLink, the owner of a high–capacity optic–fibre submarine cable directly connecting Europe and Latin America, and the Ministère de la... More >>
Mavenir finalise une recapitalisation complète
La transaction élimine plus de 1,3 milliard de dollars de dettes existantes et garantit 300 millions de dollars de nouveaux financements seniors, renforçant ainsi significativement le bilan de Mavenir.
... More >>